Search Results - "Nahnsen, S"

Number of predicted tumour-neoantigens as biomarker for cancer immunotherapies by Armeanu-Ebinger, S., Hadaschik, D., Kyzirakos, C., Mohr, C., Battke, F., Kohlbacher, O., Nahnsen, S., Biskup, S.

Get full text

The nf-core framework for community-curated bioinformatics pipelines by Ewels, Philip A., Peltzer, Alexander, Fillinger, Sven, Patel, Harshil, Alneberg, Johannes, Wilm, Andreas, Garcia, Maxime Ulysse, Di Tommaso, Paolo, Nahnsen, Sven

Get full text

Genetic evolution of in situ follicular neoplasia to t(14;18)-positive aggressive B-cell lymphoma by Vogelsberg, A, Steinhilber, J, Mankel, B, Federmann, B, Schmidt, J, Montes-Mojarro, I A, Hüttl, K, Rodriguez-Pinilla, M, Baskaran, P, Nahnsen, S, Piris, M A, Ott, G, Quintanilla-Martinez, L, Bonzheim, I, Fend, F

“…In situ follicular neoplasia (ISFN) is a t(14;18)(q32;q21) precursor lesion of follicular lymphoma (FL), which in turn can transform into diffuse large B‑cell…”
Get full text

P13.04.A REPRODUCIBLE CRISPR-SEQ PIPELINE FOR NGS FUNCTIONAL GENOMICS SCREENINGS FOR GLIOMA CELL LINES by Kuhlburger, L, Mir Pedrol, J, Haeusser, L A, Walter, B, Gabernet, G, Merk, D, Tabatabai, G, Nahnsen, S

“…Abstract BACKGROUND The CRISPR/Cas9 genome editing technology has revolutionized the field of functional genomics by enabling precise editing of DNA. Over the…”
Get full text

P10.25.A ATR INHIBITION IN EXPERIMENTAL GLIOMA: DISCOVERY AND VALIDATION OF MOLECULAR TARGETS FOR FUNCTIONALLY-INSTRUCTED COMBINATION THERAPIES by Walter, B, Hirsch, S, Kuhlburger, L, Stahl, A, Schnabel, L, Haeusser, L A, Tsiami, F, Ploeger, S, Aghaallaei, N, Dick, A M, Skokowa, J, Schmees, C, Templin, M, Schenke-Layland, K, Tatagiba, M, Nahnsen, S, Merk, D, Tabatabai, G

“…Abstract BACKGROUND The DNA damage response (DDR) is an important physiological network for the prevention of malignant transformation, e.g. by halting the…”
Get full text

Optimized neoantigen selection based on tumor exome data by Kyzirakos, C., Mohr, C., Armeanu-Ebinger, S., Feldhahn, M., Hadaschik, D., Walzer, M., Döcker, D., Menzel, M., Nahnsen, S., Kohlbacher, O., Biskup, S.

Get full text

Die genetische Evolution der in situ follikulären Neoplasie zum t(14;18)-positiven aggressiven B‑Zell-Lymphom by Vogelsberg, A., Steinhilber, J., Mankel, B., Federmann, B., Schmidt, J., Montes-Mojarro, I. A., Hüttl, K., Rodriguez-Pinilla, M., Baskaran, P., Nahnsen, S., Piris, M. A., Ott, G., Quintanilla-Martinez, L., Bonzheim, I., Fend, F.

“…Zusammenfassung Hintergrund Die in situ follikuläre Neoplasie (ISFN) ist eine t(14;18)(q32;q21) + Vorläuferläsion des follikulären Lymphoms (FL), das…”
Get full text